Table 5.
Comparison of studies concerning management and outcomes of aortic valve endocarditis complicated by periannular abscess
| Reference | n | NVE vs PVE | Prosthesis Bio vs Mech |
Offending Microorganisms | Mortality | Freedom from re-endocarditis | Freedom from re-operation | Survival | Comment |
|---|---|---|---|---|---|---|---|---|---|
| Present study | 69 | 51–49% | 28–72% |
Staphylococci: 28% Streptococci: 28% Enterococci: 4% |
13% (30-day) 16% (120-day) 36% (overall) |
83.5 ± 13.3% (10 years) |
85.9 ± 10.6% (10 years) |
69 ± 12% (5 years) 56 ± 14% (10 years) |
|
| Kirali (2016) [28] | 27 | 78–22% | 7–36% |
Staphylococci: 37% Streptococci: 15% Enterococci: 11% |
22% (hospital) 26% (30-day) |
63 ± 6% (5 years) 59 ± 7% (10 years) |
Inclusion ARR patients | ||
|
Takahashi (2013) [18] |
25 | 68–32% | 36–64% |
Staphylococci: 48% Streptococci: 16% Enterococci: 12% |
20% (30-day) | 100% (3 years) | 100% (3 years) | 80 ± 8% (3 years) | Patients with LV-Ao discontinuity |
|
Leontyev (2012) [16] |
172 | 56–44% | 82–11% |
Staphylococci: 40% Streptococci: 23% Enterococci: 15% |
25% (30-day) | 80 ± 4% (5 years) | 50 ± 4% (5 years) | Ao allograft 7.5% | |
|
David (2007) [13] |
135 | 51–49% | 41–49% |
Staphylococci: 46% Streptococci: 26% Enterococci: 4% |
16% (operative) |
88 ± 3% (5 years) 82 ± 4% (10 years) 82 ± 4% (15 years) |
96 ± 2% (5 years) 84 ± 5% (10 years) 72 ± 9% (15 years) |
71 ± 4% (5 years) 57 ± 5% (10 years) 43 ± 6% (15 years) |
Ao allograft 10% |
|
Naqvi (2005) [17] |
45 | 47–53% |
Staphylococci: 56% Streptococci: 9% Enterococci: 16% |
31% (hospital) | 62% (1 year) | 37 (82%) patients had surgery | |||
|
Anguera (2005) [4] a |
67 | 60–40% |
Staphylococci: 36% Streptococci: 28% Enterococci: 12% |
19% (hospital) | IE with abscess vs without | ||||
|
Knosalla (2000) [15] |
65 | 72–28% | 5–23% |
Staphylococci: 40% Streptococci: 35% Enterococci: 12% |
24% (30-day) 89% (allograft) |
72% (11 years) 97% (allograft) |
73% (11 years) 90% (allograft) |
65% (11 years) 82% (allograft) |
Ao allograft 72% |
|
d’Udekem (1996) [14] |
70 | 49–51% | 43–51% |
Staphylococci: 53% Streptococci: 30% Enterococci: 3% |
13% (operative) | 76 ± 10% (8 years) | 4.3% | 64 ± 8% (8 years) | Ao allograft 6% |
Ao aorta, ARR aortic root replacement, IE infective endocarditis, LV left ventricle, NVE native valve endocarditis, PVE prosthetic valve endocarditis
a Multicentre study